China Peripheral Artery Disease Interventional Landscape, Procedure Volumes, Brand Perception and Future Outlook (2019-2022)

September 2022
The China Peripheral Artery Disease (PAD) report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with more than 100 performing physicians in Interventional Radiology, Interventional Cardiology, Vascular Surgery, and General Surgery departments from level 2 and level 3 hospitals in China.

The report covers:

  • Peripheral interventional procedures: lower extremity and upper extremity procedures
  • Interventional devices: peripheral stents, peripheral angioplasty balloons, atherectomy devices, carotid artery stents, and embolic protection devices.
  • Procedure trends: by facility type, stages of the disease, artery location, performing departments, route of access used for the intervention, and patient discharge.

I have learned about many atherectomy techniques (rotational, directional, and laser) at academic conferences, but I have never used laser because no sales representative has come to my hospital for introduction of these techniques. I’m very interested in laser ablation atherectomy, and I am not the only one. ”

– Chief Vascular Surgeon, Level 3 Hospital, Beijing, China 2020

  • 45% of peripheral interventions are performed by vascular surgeons
  • ~50% of PAD procedures are performed in mild-moderate claudication
  • 30% of atherectomy procedures use rotational atherectomy devices

Physicians’ brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others effecting brand usage have been covered. Future trends such as the continued increase in usage of drug-coated balloons and drug-eluting stents are expected to drive the procedure volume growth, laser and rotational atherectomy usage are expected to increase in the future. The increased adoption of newer techniques such as deep vein arterialization, and a decrease in the atherectomy procedural cost are potential game changers to watch out for in the growing PAD interventional devices market.

Competitor landscape covers market events such as emerging companies, product approvals, clinical trials, partnerships etc. Competitor activities such as the recent NMPA (National Medical Products Association) approval of the Shockwave M5 and S4 Peripheral IVL Catheters by Genesis MedTech Group; Information on ongoing clinical trials by domestic companies such as Zhejiang Zylox Medical Device Co., Ltd. and the ongoing trial for safety and efficacy for BeGraft peripheral stent graft by Bentley Innomed GmbH (in collaboration with Shanghai Micro Medical Devices Co. Ltd) are covered in the report.

What’s in it for you?

  • This report will help peripheral artery devices (PAD) interventional devices companies understand the peripheral artery intervention landscape in China, procedural and technology trends, the brand perception, in China.
  • The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the PAD interventional devices market.
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model.
Contact us below for further details regarding the exclusive data and insights in the report or for an exploratory analyst walkthrough of the report.

We provide the best insights for your business